Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Pain Management

  Free Subscription


Articles published in Eur J Pharmacol

Retrieve available abstracts of 39 articles:
HTML format



Single Articles


    October 2022
  1. CAO J, Liu X, Liu JX, Zhao S, et al
    Inhibition of glutamatergic neurons in layer II/III of the medial prefrontal cortex alleviates paclitaxel-induced neuropathic pain and anxiety.
    Eur J Pharmacol. 2022 Oct 26:175351. doi: 10.1016/j.ejphar.2022.175351.
    PubMed     Abstract available


    September 2022
  2. XU Y, Jiang Z, Chen X
    Mechanisms underlying paclitaxel-induced neuropathic pain: Channels, inflammation and immune regulations.
    Eur J Pharmacol. 2022 Sep 16:175288. doi: 10.1016/j.ejphar.2022.175288.
    PubMed     Abstract available


  3. LIN J, Fang X, Liu F, Zhang Y, et al
    Corrigendum to "P2Y14 receptor in trigeminal ganglion contributes to neuropathic pain in mice" [Eur. J. Pharmacol. 931 (2022) 175211].
    Eur J Pharmacol. 2022 Sep 9:175266. doi: 10.1016/j.ejphar.2022.175266.
    PubMed    


    August 2022
  4. LIN J, Fang X, Liu F, Zhang Y, et al
    P2Y14 receptor in trigeminal ganglion contributes to neuropathic pain in mice.
    Eur J Pharmacol. 2022 Aug 15:175211. doi: 10.1016/j.ejphar.2022.175211.
    PubMed     Abstract available


    June 2022
  5. LI DY, Gao SJ, Sun J, Zhang LQ, et al
    Notch signaling activation contributes to paclitaxel-induced neuropathic pain via activation of A1 astrocytes.
    Eur J Pharmacol. 2022;928:175130.
    PubMed     Abstract available


    May 2022
  6. BLOMS-FUNKE P, Schumacher M, Liu S, Su D, et al
    A novel dual mode-of-action anti-hyperalgesic compound in rats which is neuroprotective and promotes neuroregeneration.
    Eur J Pharmacol. 2022;923:174935.
    PubMed     Abstract available


  7. PATRAD E, Khalighfard S, Khori V, Alizadeh AM, et al
    The other side of the coin: Positive view on the role of opioids in cancer.
    Eur J Pharmacol. 2022;923:174888.
    PubMed     Abstract available


    April 2022
  8. JAIN MR, Patel RB, Prajapati KD, Vyas P, et al
    ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models.
    Eur J Pharmacol. 2022 Apr 17:174961. doi: 10.1016/j.ejphar.2022.174961.
    PubMed     Abstract available


  9. SIVAKUMAR D, Ramli R
    GABAergic signalling in modulation of dental pain.
    Eur J Pharmacol. 2022;924:174958.
    PubMed     Abstract available


    March 2022
  10. ARAYA EI, Baggio DF, Koren LO, Schwarting RKW, et al
    Trigeminal neuropathic pain reduces 50-kHz ultrasonic vocalizations in rats, which are restored by analgesic drugs.
    Eur J Pharmacol. 2022;922:174905.
    PubMed     Abstract available


  11. QUEIROZ BFG, Fonseca FCS, Ferreira RCM, Romero TRL, et al
    Analgesia and pain: Dual effect of dopamine on the peripheral nociceptive system is dependent on D2-or D1-like receptor activation.
    Eur J Pharmacol. 2022 Mar 14:174872. doi: 10.1016/j.ejphar.2022.174872.
    PubMed     Abstract available


    February 2022
  12. RODRIGUEZ-PALMA EJ, Castelo-Flores DG, Caram-Salas NL, Salinas-Abarca AB, et al
    Sex-dependent antiallodynic effect of alpha2 adrenergic receptor agonist tizanidine in rats with experimental neuropathic pain.
    Eur J Pharmacol. 2022 Feb 25:174855. doi: 10.1016/j.ejphar.2022.174855.
    PubMed     Abstract available


    January 2022
  13. WANG Y, Qin D, Guo Z, Shi F, et al
    Research progress on the potential novel analgesic BU08028.
    Eur J Pharmacol. 2022;914:174678.
    PubMed     Abstract available


    November 2021
  14. TAMADA M, Ohi Y, Kodama D, Miyazawa K, et al
    Modulation of excitatory synaptic transmissions by TRPV1 in the spinal trigeminal subnucleus caudalis neurons of neuropathic pain rats.
    Eur J Pharmacol. 2021;913:174625.
    PubMed     Abstract available


  15. LI T, Wang L, Zhang L, Li B, et al
    Rotigotine-loaded microspheres exerts the antinociceptive effect via central dopaminergic system.
    Eur J Pharmacol. 2021;910:174443.
    PubMed     Abstract available


    October 2021
  16. ZHAO L, Tao X, Song T
    Astaxanthin alleviates neuropathic pain by inhibiting the MAPKs and NF-kappaB pathways.
    Eur J Pharmacol. 2021;912:174575.
    PubMed     Abstract available


    September 2021
  17. NAFFAA MM, Al-Ewaidat OA
    Ligand modulation of KCNQ-encoded (KV7) potassium channels in the heart and nervous system.
    Eur J Pharmacol. 2021;906:174278.
    PubMed     Abstract available


    August 2021
  18. ISHIDA H, Yamaguchi M, Saito SY, Furukawa T, et al
    Na(+)-dependent inactivation of vascular Na(+)/Ca(2+) exchanger responsible for reduced peripheral blood flow in neuropathic pain model.
    Eur J Pharmacol. 2021;910:174448.
    PubMed     Abstract available


  19. FU J, Xu M, Xu L, Ni H, et al
    Sulforaphane alleviates hyperalgesia and enhances analgesic potency of morphine in rats with cancer-induced bone pain.
    Eur J Pharmacol. 2021;909:174412.
    PubMed     Abstract available


  20. VILLALUZ M, Dunning L, Goodyear CS, Ferrell WR, et al
    Losartan protects endothelium-dependent relaxation in vivo in a murine model of rheumatoid arthritis.
    Eur J Pharmacol. 2021;904:174133.
    PubMed     Abstract available


    July 2021
  21. YANG F, Zou YQ, Li M, Luo WJ, et al
    Intervertebral foramen injection of plerixafor attenuates neuropathic pain after chronic compression of the dorsal root ganglion: Possible involvement of the down-regulation of Nav1.8 and Nav1.9.
    Eur J Pharmacol. 2021;908:174322.
    PubMed     Abstract available


  22. KHAN J, Ali G, Rashid U, Khan R, et al
    Mechanistic evaluation of a novel cyclohexenone derivative's functionality against nociception and inflammation: An in-vitro, in-vivo and in-silico approach.
    Eur J Pharmacol. 2021;902:174091.
    PubMed     Abstract available


    June 2021
  23. GUO ZB, Tang L, Wang LP, Wu HH, et al
    The analgesic effects of ulinastatin either as a single agent or in combination with sufentanil: A novel therapeutic potential for postoperative pain.
    Eur J Pharmacol. 2021;907:174267.
    PubMed     Abstract available


    May 2021
  24. SPRING DE ALMEIDA A, de Barros Bernardes L, Trevisan G
    TRP Channels in Cancer Pain.
    Eur J Pharmacol. 2021 May 17:174185. doi: 10.1016/j.ejphar.2021.174185.
    PubMed     Abstract available


  25. YAO L, Zhang TY, Diao XT, Ma JJ, et al
    Functional expression of glycine receptors in DRG neurons of mice.
    Eur J Pharmacol. 2021;899:174034.
    PubMed     Abstract available


  26. MUCHHALA KH, Jacob JC, Dewey WL, Akbarali HI, et al
    Role of beta-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.
    Eur J Pharmacol. 2021;899:174007.
    PubMed     Abstract available


    April 2021
  27. ZHANG T, Zhang R, Xu B, Zhang M, et al
    Spinal endomorphins attenuate burn-injury pain in male mice by inhibiting p38 MAPK signaling pathway through the mu-opioid receptor.
    Eur J Pharmacol. 2021;903:174139.
    PubMed     Abstract available


  28. DIAS QUINTAO JL, Reis Gonzaga AC, Galdino G, Lima Romero TR, et al
    TNF-alpha, CXCL-1 and IL-1 beta as activators of the opioid system involved in peripheral analgesic control in mice.
    Eur J Pharmacol. 2021;896:173900.
    PubMed     Abstract available


  29. GONCALVES WA, Ferreira RCM, Rezende BM, Mahecha GAB, et al
    Endogenous opioid and cannabinoid systems modulate the muscle pain: a pharmacological study into the peripheral site.
    Eur J Pharmacol. 2021 Apr 4:174089. doi: 10.1016/j.ejphar.2021.174089.
    PubMed     Abstract available


    March 2021
  30. XU Q, Sun L, Zhang W, Wu H, et al
    A novel visceral pain model of uterine cervix inflammation in rat.
    Eur J Pharmacol. 2021;900:174080.
    PubMed     Abstract available


  31. SHEIKHOLESLAMI MA, Ghafghazi S, Parvardeh S, Koohsari S, et al
    Analgesic effects of cuminic alcohol (4-isopropylbenzyl alcohol), a monocyclic terpenoid, in animal models of nociceptive and neuropathic pain: Role of opioid receptors, L-arginine/NO/cGMP pathway, and inflammatory cytokines.
    Eur J Pharmacol. 2021;900:174075.
    PubMed     Abstract available


  32. DAI G, Li B, Xu Y, Li Z, et al
    Synergistic interaction between matrine and paracetamol in the acetic acid writhing test in mice.
    Eur J Pharmacol. 2021;895:173869.
    PubMed     Abstract available


    February 2021
  33. MENA-VALDES LC, Blanco-Hernandez Y, Espinosa-Juarez JV, Lopez-Munoz FJ, et al
    Haloperidol potentiates antinociceptive effects of morphine and disrupt opioid tolerance.
    Eur J Pharmacol. 2021;893:173825.
    PubMed     Abstract available


  34. ALIJANPOUR S, Jafaripour S, Ghasemzadeh Z, Khakpai F, et al
    Harmaline potentiates morphine-induced antinociception via affecting the ventral hippocampal GABA-A receptors in mice.
    Eur J Pharmacol. 2021;893:173806.
    PubMed     Abstract available


    January 2021
  35. RICARDO CARVALHO VP, Figueira da Silva J, Buzelin MA, Antonio da Silva Junior C, et al
    Calcium channels blockers toxins attenuate abdominal hyperalgesia and inflammatory response associated with the cerulein-induced acute pancreatitis in rats.
    Eur J Pharmacol. 2021;891:173672.
    PubMed     Abstract available


  36. DECIGA-CAMPOS M, Villafan-Gutierrez R, Espinosa-Juarez JV, Jaramillo-Morales OA, et al
    Synergistic interaction between haloperidol and gabapentin in a model of neuropathic nociception in rat.
    Eur J Pharmacol. 2021;891:173702.
    PubMed     Abstract available


  37. CAMARGO LL, Denadai-Souza A, Yshii LM, Lima C, et al
    The potential anti-inflammatory and anti-nociceptive effects of rat hemopressin (PVNFKFLSH) in experimental arthritis.
    Eur J Pharmacol. 2021;890:173636.
    PubMed     Abstract available


    September 2020
  38. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Eur J Pharmacol. 2020;887:173565.
    PubMed     Abstract available


  39. KUBACKA M, Rapacz A, Salat K, Filipek B, et al
    KM-416, a novel phenoxyalkylaminoalkanol derivative with anticonvulsant properties exerts analgesic, local anesthetic, and antidepressant-like activities. Pharmacodynamic, pharmacokinetic, and forced degradation studies.
    Eur J Pharmacol. 2020 Sep 4:173540. doi: 10.1016/j.ejphar.2020.173540.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pain Management is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: